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Abstract
Matrin 3 (MATR3) is a highly conserved, inner nuclear matrix protein with two zinc finger domains and two RNA recognition
motifs (RRM), whose function is largely unknown. Recently we found MATR3 to be phosphorylated by the protein kinase
ATM, which activates the cellular response to double strand breaks in the DNA. Here, we show that MATR3 interacts in an
RNA-dependent manner with several proteins with established roles in RNA processing, and maintains its interaction with
RNA via its RRM2 domain. Deep sequencing of the bound RNA (RIP-seq) identified several small noncoding RNA species.
Using microarray analysis to explore MATR39s role in transcription, we identified 77 transcripts whose amounts depended
on the presence of MATR3. We validated this finding with nine transcripts which were also bound to the MATR3 complex.
Finally, we demonstrated the importance of MATR3 for maintaining the stability of several of these mRNA species and
conclude that it has a role in mRNA stabilization. The data suggest that the cellular level of MATR3, known to be highly
regulated, modulates the stability of a group of gene transcripts.
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Introduction
Matrin 3 (MATR3) is a highly conserved, inner nuclear matrix
protein of 125 kDa [1]. Nuclear matrix proteins bound to the
inner nuclear membrane form a skeletal nuclear framework with
roles in chromatin organization, DNA replication, transcription,
repair, and RNA processing and transport [2]. MATR3 contains a
bipartite nuclear localization signal (NLS) [3], two zinc finger
domains predicted to bind DNA, and two RNA recognition motifs
(RRM). Rat MATR3 was shown to bind DNA [4,5], but an RNA
binding activity was never attributed to MATR3. A missense
mutation in a domain-less area on MATR3 was recently found to
cause adult-onset autosomal dominant vocal cord and pharyngeal
weakness with distal myopathy (VCPDM) [6]. Together with the
proteins SFPQ (PSF) and NONO (p54nrb), MATR3 has been
implicated in the nuclear retention of hyper-edited mRNA, which
prevented its translation [7]. Recently we found MATR3 to be
phosphorylated in response to the induction of double strand
breaks in the DNA. This phosphorylation depended the nuclear
protein kinase ATM. Notably, SFPQ and NONO were also
implicated in the DNA damage response in that study [8].
MATR3 was reported to be phosphorylated by the protein
kinase PKA following activation of the NMDA receptors, which
led to its degradation [9]. A proteomic screen revealed that
MATR3 binds to calmodulin and it was suggested that it is cleaved
by both caspase-3 and caspase-8 [10]. MATR3 levels decrease
after treatment with soy extract of homocysteine-stressed endo-
thelial cells [11], and are reduced in the brain of Down syndrome
fetuses [12]. It has recently been suggested that the microRNA
miR-200b, which may be involved in massive macronodular
adrenocortical disease (MMAD), modulates MATR3 cellular
amounts [13]. However, taken together these studies do not point
at a specific role for MATR3 in cellular metabolism.
Following our earlier observation of MATR39s involvement in
the DNA damage response [8], we set out to further explore its
cellular functions. Proteomic analysis revealed a protein-RNA
complex containing MATR3 together with other RNA metabo-
lizing enzymes, whose integrity was RNA-dependent. Identifica-
tion of several RNA species in this complex points to its
involvement in RNA processing. Our data further suggest that
MATR3 contributes to stabilizing certain mRNA species.
Results
MATR3 maintains an RNA-dependent association with
proteins involved in RNA processing
In order to obtain clues to MATR39s function we set to identify
novel MATR3-interacting proteins. FLAG-tagged MATR3 was
expressed in HEK293T cells and immunoprecipitated using anti-
FLAG antibody, with an empty vector serving as control. The
immune complexes were separated using SDS-PAGE, and the gels
underwent silver staining (Fig. 1A). Bands that came down with
MATR3 were identified using mass spectrometry.
Individual interactions with MATR3 were validated by co-
immunoprecipitation. The proteins DHX9 and HNRNPK co-
immunoprecipitated with ectopic and endogenous MATR3
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suspected that some of these interactions might require RNA
molecules. RNase treatment indeed abolished MATR39s interac-
tions with DHX9 and HNRNPK (Fig. 1C), suggesting that RNA
was necessary for maintaining these interactions.
MATR3 binds RNA via its RRM2 domain
MATR3 has two zinc finger domains that can potentially
interact with DNA, and two RRMs that are known to interact
with RNA (Fig. 2A). These domains are common to nuclear
matrix proteins, underscoring their involvement in transcription
and RNA processing. Indeed, MATR39s interactions with DHX9
and HNRNPK were RNA-dependent (Fig. 1C). We examined the
contribution of the RRM domains to MATR39s ability to bind
RNA and its interactors by preparing constructs expressing
MATR3 with deletions of one or both of its RRMs, or one of
the zinc finger domains (Fig. 2A). Notably, MATR39s ability to
bind the proteins DHX9 and HNRNPK depended on the
presence of RRM2. Deletion of the RRM1 and ZnFn2 domains
had a moderate effect on these interactions (Fig. 2B).
Analysis of RNA species associated with the MATR3
complex
Co-immunoprecipitation of MATR3 with its interactors was
RNA- and RRM2-domain-dependent, suggesting that MATR3
binds RNA molecules via its RRM2 domain, and this RNA is
important for MATR3 interactions. We undertook to identify
these RNA species. FLAG-MATR3 was immunoprecipitated from
HEK293T cells, and RNA was extracted from the immune
complexes and underwent RNA-seq using the Illumina/Solexa
technology. We used total cellular RNA as background control.
While an ideal control would have been RNA obtained from
immune complexes of RRM2-deleted MATR3, the amount of
RNA found in such immune complexes was minute and did not
allow sequencing. We thus identified 4 RNA species in MATR3
immune complexes that were significantly over-represented in
these complexes compared to their occurrence in total cellular
RNA. All of these RNAs turned out to be small noncoding RNAs
(Table 1).
The deep sequencing results were validated using qPCR.
FLAG-MATR3, FLAG-MATR3 DRRM2 and the empty vector
Figure 1. Identification of novel MATR3 interactors. (A) FLAG-MATR3 was expressed in HEK293T cells and immunoprecipitated using anti-
FLAG conjugated beads. Immune complexes were separated by SDS-PAGE and visualized with silver staining. Cells with empty vector allowed
discrimination between specific and non-specific immunoprecipitation. Bands that appeared specific were identified using mass spectrometry. (B)
FLAG-MATR3 was expressed in HEK293T cells and immunoprecipitated using FLAG-conjugated beads. The immune complexes were blotted with the
indicated antibodies. (C) Endogenous MATR3 was immunoprecipitated from HEK293T cells, and the immune complexes were treated with RNase A
and blotted with antibodies against the indicated proteins.
doi:10.1371/journal.pone.0023882.g001
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using FLAG-conjugated beads, and RNA was extracted from the
immune complexes. Phe-tRNA from S. Cerevisiae was added to this
RNA as an exogenic control. The results confirmed that all 4 small
noncoding RNAs co-immunoprecipitated with wild type MATR3
(Figs. 3A and B).
Effect of MATR3 loss on the cellular transcriptome
Since the small noncoding RNA 7SK and the protein DHX9
are involved in transcription regulation [14,15,16,17,18] and
HNRNPK is a co-activator of p53 [19], we asked whether
MATR3 depletion would affect the cellular transcriptome. We
depleted U2OS cells of MATR3 using RNAi (Fig. 4A) and
examined the effect on gene expression patterns using microarray
analysis. While MATR3 was not required for transcription of p53
target genes (Fig. S1), we identified a cluster of 77 genes whose
expression levels were reduced in MATR3-depleted cells (Fig. 4B
and Table S1). These results were validated for 9 transcripts using
qPCR . Indeed, the levels of all 9 transcripts were reduced
following MATR3 depletion to 55–75% of their levels in control
cells (Fig. 4C).
MATR3 binds mRNAs
We asked whether MATR3 maintained physical interaction
with mRNAs whose levels were reduced following its depletion.
Such mRNAs may not have been over-represented initially in
MATR3 immunoprecipitates due to their low abundance. Using
qPCR we examined specifically the presence of 9 mRNAs of this
group in MATR3 immunoprecipitates, with GAPDH mRNA
serving as control. Importantly, all mRNAs were found to bind
wild type but not DRRM2-MATR3 (Fig 4D). These results suggest
that MATR3 interacts physically with specific transcripts whose
levels are affected by its presence.
MATR3 affects mRNA stability
In view of the interaction between MATR3 and mRNAs whose
amounts were affected by its depletion, we asked whether MATR3
is involved in maintaining the stability of these mRNAs. We
measured the half-life of 3 mRNAs in this group (HLTF,
RP56KA4, HNT) in cells proficient or deficient of MATR3, by
monitoring the decay of these mRNAs after inhibition of de novo
transcription using actinomycin D. Indeed, MATR3 depletion
reduced the stability of the 3 mRNAs compared to GAPDH
mRNA (Fig. 5). This reduction in stability could account for the
decrease in the amounts of these mRNAs following MATR3
depletion.
Figure 2. MATR3 binds RNA via its RRM2 domain. (A) Schematic presentation of MATR3 domains and deletion of specific domains in different
constructs used in this study. (B) HEK293T cells were transfected with the indicated MATR3 expression constructs. FLAG-conjugated beads were used
for immunoprecipitation and the immune complexes were blotted with the indicated antibodies.
doi:10.1371/journal.pone.0023882.g002
Table 1. Small noncoding RNAs identified in MATR3
immunoprecipitates.
Designation Accession no. Documented function
U4 NR_003925 mRNA splicing [36].
SNORA73A NR_002907 Possible role in rRNA proccesing [37,38].
7SK NR_001445 Inhibition of transcription elongation [25].
RMRP NR_003051 rRNA processing and endonuclease
activity [39].
doi:10.1371/journal.pone.0023882.t001
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MATR39s activity and mode of action are unclear, but its
domains predict a role in RNA metabolism. We identified DHX9
and HNRNPK as new interactors of MATR3. DHX9 is a DNA
and RNA helicase with diverse physiological functions in
transcription, RNA processing, transport [20] and translation
[21]. HNRNPK, a component of the heterogeneous nuclear
ribonucleoprotein complex, is involved in chromatin remodeling
and mRNA transcription, splicing and translation [22].
In view of the involvement of MATR39s RRM domains and its
new interactors in RNA metabolism, we asked whether RNA is
involved in these interactions and found them to be dependent on
both RNA and the RRM2 domain of MATR3. Furthermore, we
obtained a first demonstration that MATR3 is an RNA-binding
protein. Deep sequencing of bound RNA identified several small
noncoding RNAs, which were over-represented in MATR3
immunoprecipitates and whose binding depended on MATR39s
RRM2 domain. Interestingly, one of these RNAs was 7SK, which
is known to bind HNRNPK [14,23,24,25,26,27] and DHX9
proteins [23]. 7SK is a regulator of the P-TEFb kinase, which
phosphorylates RNA polymerase II to promote transcription
elongation [28,29]. Thus, our data point to a protein complex
containing MATR3, DHX9 and HNRNPK and the 7SK RNA. It
is known that depletion of HNRNPK changes 7SK’s interaction
with its surrounding proteomic environment [24]. In our
experiments, depletion of MATR3 did not exert a similar effect
(data not shown).
While HNRNPK was shown to co-activate p53, our microarray
analysis indicated that MATR3 is not involved in p53 activation
(Fig. S1). However, MATR3 depletion led to decreased amounts
of 77 mRNAs (Fig. 4A). MATR3 binding of 9 transcripts of this
group (Fig. 4C) was further validated (Fig. 4D), and further
experiments suggested that MATR3 is involved in controlling the
levels of these transcripts by affecting their stability (Fig. 5).
The half-life of mRNA molecules is affected by specific
sequences usually located in the 39 UTR, and is regulated by
RNA-binding proteins that bind to these sequences (48,49). An
extensively documented example is the ARE sequence, a short
sequence (AUUUA) found in the 39 UTR of many mRNAs
(50,51). RNA-binding proteins such as the Hu proteins bind to this
sequence and enhance the stability of the corresponding mRNAs
(52,53). The steady-state levels of the mRNAs thus depend on the
balance between their own production and the levels and activity
of proteins that stabilize them or enhance their degradation.
The levels of cellular MATR3 are highly regulated [9,10,11,
12,13]. We suggest that this tightly regulated protein stabilizes a
number of transcripts, probably via direct interaction with these
RNA species. We also propose that MATR3 is part of a protein
complex containing, among others, the DHX9 and HNRNPK
proteins as well as small noncoding RNAs such as 7SK. DHX9
and HNRNPK as well as the 7SK RNA were previously found to
be involved in transcription and several RNA processes such as
splicing [22,30,31]. Identification of MATR3 as another player in




HEK293T (ATCC Number: CRL-11268) and U2OS (ATCC
Number: HTB-96) cells were grown in DMEM supplemented
with 10% fetal bovine serum, at 37uC and 5% CO2 atmosphere.
Antibodies and other reagents
Polyclonal antibodies against MATR3, DHX9, and HNRNPK
were obtained from Bethyl Laboratories (Montgomery, TX).
FLAG-conjugated beads were purchased from Sigma-Aldrich,
RNase A from RBC (Taipei, Taiwan), neocarzinostatin from
KayaKU Chemicals (Tokyo, Japan) and actinomycin D from
Sigma-Aldrich.
Expression constructs
A full-length cDNA clone of MATR3, KIAA0723, was obtained
from the Kazusa DNA Research Institute (Kisarazu, Japan) and
cloned into pCMV:FLAG2B vector. Deletions in the cDNA were
generated by Pfu polymerase amplification using the MATR3
construct as template and primers flanking the domain to be deleted.
Immunoblotting and immunoprecipitation
Immunoblotting and immunoprecipitation were carried out
according to standard techniques. Briefly, cells were harvested and
lysed in RIPA lysis buffer, and the lysates were run on 8% SDS
PAGE and transferred onto a nitrocellulose membrane. For
immunoprecipitation, cells were washed twice with ice-cold PBS,
harvested, and lysed for 30 min on ice in 0.5% NP40, 150 Mm
NaCl, 50 Mm Tris pH7.5, and 1 mM EDTA supplemented with
a mixture of protease and phosphatase inhibitors. Supernatants
were collected and the primary antibody was added for 2 hr at
4uC. Protein A and G sepharose beads were added for an
additional 1 hr, after which the beads were washed 4 times. Beads
were boiled in sample buffer and loaded onto the gel. In the RNA-
IP experiment the RNA was extracted from the immune
complexes after the above IP procedure. Mass spectrometric
analysis was carried out as previously described [32].
Figure 3. Validation of RIP-seq results. (A) HEK293T cells were
transfected with the indicated MATR3 constructs and the ectopic
MATR3 proteins were immunoprecipitated using FLAG-conjugated
beads and blotted with the indicated antibodies. (B) RNA was extracted
from the immune complexes, yeast Phe-tRNA was added, qPCR was
carried out on reverse transcription products and the Relative
Quantification (RQ) is shown as fold-change of signal compared to
DRRM2 minus the background of the empty vector. The plot represents
the mean of three independent experiments and error bars represent
SD (*P#0.05, **P#0.01, t test).
doi:10.1371/journal.pone.0023882.g003
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RNA duplexes of 19 nucleotides (AGACTTCCATG-
GACTCTTA) targeting human MATR3 mRNA were designed,
and subsequently synthesized by Dharmacon (Lafayette, CO) with
the OnTarget Plus modifications. The above oligonucleotide was
used for the microarray experiment and subsequent experiments
were carried out using OnTarget Plus SMARTpool against
MATR3, which was obtained from Dharmacon (Lafayette, CO).
U2OS cells were grown to 20%–50% confluency and transfected
with siRNA using the DharmaFECT 1 reagent (Lafayette, CO).
Figure 4. MATR3 affects the transcript level of mRNAs that bind to it. (A) Knockdown of MATR3 in U2OS cells: western blotting analysis of
total cellular extracts 96 hr after transfection with siGFP or siMATR3. (B) Effect of MATR3 depletion on the expression of 77 human genes. Expression
profiles were recorded in U2OS cells knocked-down for MATR3 and in control cells transfected with siGFP, using Affymetrix Human Gene 1.0 ST arrays.
Responding genes in the datasets (defined as showing at least 1.7 fold-change in expression level) underwent clustering analysis using the CLICK
algorithm [35]. A cluster containing 77 genes was obtained containing genes whose expression level was reduced in MATR3 knocked-down cells
(Table S1). The plot represents average expression levels of these genes normalized against their average level of expression in the siGFP samples.
(C) Validation of results obtained using microarray analysis. RNA was extracted from U2OS cells knocked-down for MATR3 and from control cells
transfected with siGFP was reverse transcribed, and qPCR was carried out. Shown is the relative quantification (RQ) as fold-change compared to the
siGFP cells. Two endogenous control transcripts were used: GAPDH and hTBP. The plot represents the mean of three independent experiments and
error bars represent SD (*P#0.05, **P#0.01, t test). (D) Binding of mRNAs to MATR3. The extent of binding of mRNAs to wild type vs. DRRM2 served
as a measure of mRNA binding to the protein. RNA was extracted from the MATR3 immune complexes shown in Figs. 3A and Phe-tRNA was added.
qPCR was carried out on reverse transcription products and the Relative Quantification (RQ) is shown as fold-change of signal compared to DRRM2
minus the background of the empty vector. The plot represents the mean of three independent experiments and error bars represent SD (*P#0.05,
**P#0.01, t test).
doi:10.1371/journal.pone.0023882.g004
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RNA was isolated from cells or immune complexes using the
RNeasy plus mini kit (QIAGEN).
RNase treatment
Following protein immunoprecipitation, immune complexes
bound to beads were washed twice with lysis buffer containing
0.5% NP-40 and suspended in the same buffer containing 0.1 mg/
ml of RNase A for 15 min at room temperature.
Preparation of libraries for Illumina sequencing platform
Libraries were prepared as described in Sultan et al. 2008 [33]
with the following modifications: just before library amplification,
uridine digestion was performed at 37uC for 15 min in 5 ml of 1xTE
buffer, pH 7.5, with 1 U of UNG (Applied Biosystems, Foster City,
CA); different ligation adapters and PCR primers were used (for
paired-end sequencing, Illumina kit #PE-102-1002).
Solexa sequencing
The SOAP program [34] was used to align the sequence reads
to genomic sequences. Reads containing mismatches to genomic
sequences aligning to multiple genomic positions were disregard-
ed. For the remaining reads, we searched for genomic positions
aligning to at least 5 reads (p value 10ˆ-15 under a Poisson
distribution). For each gene that contained one of these positions
we counted the overall number of distinct positions with at least
one aligned read in the gene. To avoid sequencing artifacts we
removed genes that had 10 different aligned reads at most. This
process resulted in a list of 60 genes that were manually inspected.
Quantitative real-time RT–PCR
cDNA synthesis was carried out with the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). qPCR was
performed with the Power SYBR Green RT-PCR Master Mix
(Applied Biosystems) and the ABI PRISM 7900HT sequence
detection system (Applied Biosystems). The comparative Ct
method was employed to quantify transcripts, and delta Ct was
measured in triplicate.
RIP-Sequencing results were normalized against S. Cerevisiae
Phe-tRNA (Sigma-Aldrich), which was added to the samples after
RNA extraction of the immune complexes. Primers used in the
RT–PCR assays are provided in Table S2.
mRNA half-life
U2OS cells were transfected with siGFP (irrelevant siRNA) or
siRNA against MATR3, and 96 hr later the cells were treated with
actinomycin D (2 mg/ml) for different time points, and harvested
in Trizol reagent (Sigma-Aldrich). Total RNA was used for qPCR.
For each time point, amounts of mRNAs were normalized against
18S rRNA and half-lives were calculated relative to untreated
sample.
Supporting Information
Figure S1 Expression profiles were recorded in U2OS
cells knocked-down for MATR3 and in control cells
transfected with siGFP, using the Affymetrix Human
Gene 1.0 ST arrays. Profiles were measured at two time-points
(3 and 6 hr) after treatment with the radiomimetic drug
neocarzinostatin (NCS) and in time-matched untreated controls.
Responding genes in the datasets (defined as those showing at least
1.7 fold-change in expression level following NCS treatment) were
subjected to clustering analysis by the CLICK algorithm [35].
Cluster #1 contains the genes that were induced by NCS
treatment. Known targets of p53 (e.g., p21, Mdm2, Fas, Gdf15,
Apaf1) appear in this cluster.
(EPS)
Figure 5. MATR3 stabilizes mRNAs. (A) Western blotting of total cellular extracts showing the extent of MATR3 knockdown in U2OS cells 96 hr
after transfection with siGFP or siMATR3. (B) mRNA half-life was estimated by treating siGFP cells and siMATR3 cells with actinomycin D (2 mg/ml) for
the indicated time periods. HLTF, RP56KA4, HNT and GAPDH mRNA levels were measured using qPCR, normalized against 18S rRNA levels and
plotted on a scale. The plot represents the mean of three independent experiments and error bars represent SD.
doi:10.1371/journal.pone.0023882.g005
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duced in MATR3-depleted cells.
(XLS)
Table S2 Primers used for real-time PCR.
(XLS)
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